MARK1 - AR

SDL interaction

Gene Name	Gene ID	Diseases	Drugs	GO terms	Orthologs
MARK1	ENSG00000116141	No diseases in record	No drugs in record	magnesium ion binding phosphatidylserine binding protein serine/threonine kinase activity ATP binding phosphatidylinositol-4,5-bisphosphate binding tau-protein kinase activity phosphatidic acid binding	par-1 (C. elegans) par-1 (D. melanogaster)
AR	ENSG00000169083	prostate	BICALUTAMIDE DANAZOL DROMOSTANOLONE PROPIONATE ENZALUTAMIDE ETHYLESTRENOL FLUOXYMESTERONE FLUTAMIDE METHYLTESTOSTERONE NANDROLONE DECANOATE NANDROLONE PHENPROPIONATE NILUTAMIDE OXANDROLONE OXYMETHOLONE STANOZOLOL TESTOSTERONE TESTOSTERONE CYPIONATE TESTOSTERONE ENANTHATE TESTOSTERONE PROPIONATE TESTOSTERONE UNDECANOATE	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding RNA polymerase II transcription factor binding DNA binding chromatin binding transcription factor activity, sequence-specific DNA binding RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding androgen receptor activity receptor binding steroid binding androgen binding protein binding beta-catenin binding transcription factor binding zinc ion binding enzyme binding transcription regulatory region DNA binding protein dimerization activity ATPase binding POU domain binding	No GO terms in record